HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab.

Raterman, Hennie G

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab. [electronic resource] - Annals of the rheumatic diseases Apr 2013 - 560-5 p. digital

Publication Type: Clinical Trial; Journal Article

1468-2060

10.1136/annrheumdis-2011-201228 doi


Adult
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antirheumatic Agents--therapeutic use
Apolipoproteins A--analysis
Apolipoproteins B--analysis
Arthritis, Rheumatoid--blood
Atherosclerosis--blood
Cholesterol, HDL--analysis
Cholesterol, LDL--analysis
Female
Humans
Immunomodulation--drug effects
Male
Middle Aged
Proteomics
Risk Factors
Rituximab
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Treatment Outcome
Triglycerides--analysis